ARTICLE | Financial News
Momenta planning follow-on
December 8, 2010 1:09 AM UTC
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) said late Tuesday it is planning a follow-on underwritten by UBS. Further details were not disclosed. In July, FDA approved an ANDA from Momenta and the Sand...